Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2. Lycke KD, Petersen LK, Gravitt PE, Hammer A, et al. Obstet Gynecol 2022;139:680-686.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lycke KD, Petersen LK, Gravitt PE, Hammer A, et al. Known Benefits and Unknown Risks of Active Surveillance of Cervical Intraepithelial Neoplasia Grade 2. Obstet Gynecol 2022;139:680-686.
PMID: 35271554